SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)
NCT05012540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 214
Last updated 2021-08-19
Summary
Chronic inflammation and immune dysfunction play a key role in the development of tumors. The aim of the study is to investigate the predictive value of SII and PALBI grade for the patients with pancreatic cancer surgery.
Conditions
Sponsors & Collaborators
-
The Affiliated Hospital of Qingdao University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-01
- Primary Completion
- 2019-12-31
- Completion
- 2020-12-31
More Related Trials
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
NCT07034339 ·Status: RECRUITING
-
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
NCT01219829 ·Status: COMPLETED
-
Precise Gene Signature for Predicting Outcomes in PDAC
NCT05441189 ·Status: COMPLETED
-
The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma
NCT05025371 ·Status: COMPLETED
-
Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities
NCT02887599 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
NCT06000553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Detection of PDAC in Patients With Chronic Pancreatitis
NCT07104864 ·Status: COMPLETED
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
Immunologic Signatures Following Surgery for Pancreatic Cancer
NCT03001518 ·Status: COMPLETED
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy
NCT02654288 ·Status: UNKNOWN
-
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
NCT02934984 ·Status: UNKNOWN
-
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
NCT05596370 ·Status: UNKNOWN
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
NCT02977702 ·Status: COMPLETED
-
A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis
NCT06241586 ·Status: COMPLETED
-
ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer
NCT05493878 ·Status: UNKNOWN
-
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
NCT05433935 ·Status: RECRUITING
-
A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
NCT06541340 ·Status: RECRUITING ·Phase: NA
-
New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase
NCT05923567 ·Status: ACTIVE_NOT_RECRUITING
-
A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma
NCT05997147 ·Status: UNKNOWN
-
Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer
NCT05187416 ·Status: UNKNOWN
-
RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer
NCT04575363 ·Status: RECRUITING ·Phase: NA